Dr. Schoen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
915 North Grand Blvd.
4th Floor
Saint Louis, MO 63106Phone+1 314-289-6305Fax+1 314-289-6320
Summary
- Dr. Martin Schoen is a hematologist/oncologist at the St. Louis Veterans Affairs Medical Center and Saint Louis University specializes in the treatment of prostate cancer, hematologic malignancies, and breast cancer. His research focuses on outcomes, disparities, and adverse events using nationwide data available from the VA to personalize treatment of cancer.
Education & Training
- SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
- SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2013 - 2016
- University of North Carolina at Chapel HillMPH, Health Policy and Management, 2008 - 2010
- Harvard Medical SchoolClass of 2006
Certifications & Licensure
- MO State Medical License 2013 - 2025
- NC State Medical License 2012 - 2025
- AL State Medical License 2007 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Banana for Best Resident Teacher Saint Louis University Class of 2016, 2016
- Caring Physician Award SSM Saint Louis University Hospital, 2015
Clinical Trials
- Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) Start of enrollment: 2020 May 20
- Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization Start of enrollment: 2020 Jul 06
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC Start of enrollment: 2021 Jun 09
- Join now to see all
Publications & Presentations
PubMed
- Impact of Socioeconomic Deprivation on Care Quality and Surgical Outcomes for Early-Stage Non-Small Cell Lung Cancer in United States Veterans.Steven Tohmasi, Daniel B Eaton Jr, Brendan T Heiden, Nikki E Rossetti, Ana A Baumann
Cancers. 2024-11-11 - 1 citationsEarly-Stage Lung Cancer in the Era of Lung Cancer Screening: Veterans Health Administration Outperforms Other Insurance Models.Nikki E Rossetti, Daniel B Eaton Jr, Steven Tohmasi, Brendan T Heiden, Martin W Schoen
The Annals of Thoracic Surgery. 2024-11-01 - Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients ...Nikhil Grandhi, Lawrence Liu, Mei Wang, Theodore Thomas, Martin Schoen
JNCI Cancer Spectrum. 2024-11-01
Books/Book Chapters
Abstracts/Posters
- Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and BendamustineSchoen MW, Sanfilippo KM, Luo S, Mohammed KA, Carson KR, ASH 2017, Atlanta, GA, 12/2017
- Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia RiskSchoen MW, Woelich SK, Braun JT et. al, ASH 2016, San Diego, CA, 12/2016
- Outcomes of Acute Myeloid Leukemia Induction with Addition of CladribineSchoen MW, Braun J, Woelich S, Ramlal R, Schmidt A, Freter CE, Lionberger JM, Missouri ACP, First Place Award: Research Poster, 9/1/2015
- Join now to see all
Lectures
- Outcomes of Black Patients with Multiple Myeloma in the Veterans Health AdministrationAmerican Society of Hematology Annual Meeting - 12/3/2018
- Association of venous thromboembolism with increased mortality in patients with multiple myeloma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
- SLU Researcher Reports Improvements in Survival Rates in Patients with Metastatic Prostate CancerJune 20th, 2024
- Survival Edge Found Among Black US Veterans with mCRPCFebruary 17th, 2023
- Enzalutamide, Abiraterone Compared for mCRPC with ComorbiditiesDecember 1st, 2022
- Join now to see all
Research History
- Outcomes Researcher, Veterans AffairsI have conducted outcomes research in the Veterans Affairs to understand differences in treatment based on comorbidities and race.2016 - Present
- Project Manager/ResearcherCenter for Public Health Systems Science at Washington University in St. Louis2012 - 2013
- Student InvestigatorDivision of Sleep Medicine, Harvard Medical School2003 - 2006
Professional Memberships
- Associate
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: